World Wires · story 23076 · unverified · 1 source(s)

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market

ORION CORPORATION PRESS RELEASE 6 OCTOBER 2026 at 9.00 EEST

Open in the desk

Coverage

• Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market GlobeNewswire: public companies · tier D · clear net · 2026-10-06 06:00 UTC

What this site indexes